Men provide a reservoir for continued transmission of C. trachomatis to women, thus representing a population for potential targeted screening. There are no formal recommendations by professional organizations for screening men for chlamydia, however, guidance has been provided by the Centers for Disease Control and Prevention for clinical sites wishing to screen men, who are primarily asymptomatic. This article describes and reviews the methods for laboratory diagnosis of Chlamydia trachomatis in men. The current recommendations for screening heterosexual men for chlamydia is using urine and testing by nucleic acid amplification tests (NAATs).
This resource was created by the National Chlamydia Coalition